Search ARM

ARM Events

Jump To:

Cell & Gene Therapies State of the Industry Briefing

Back to ARM Events

Cell & Gene Therapies State of the Industry Briefing

About the Briefing

Join us for the Alliance for Regenerative Medicine’s 9th Annual Cell & Gene Therapies State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This event – which is free and open to the public – will highlight the commercialization of cell-based therapies for oncology, as well as an in-depth conversation between top CEOs and executives regarding future inflection points for gene therapies expected in 2019. With an anticipated audience of over 500, this session is the largest cell and gene therapy-focused event taking place during JP Morgan week.

 

2019 Preliminary Agenda

8:00am – 8:20am | Introduction & Industry Update

Janet Lambert, CEO, Alliance for Regenerative Medicine

8:20am – 9:05am | Cell Therapy Commercialization in Oncology

Joanna Beck, EVP, Global Pharmaceutical Development and Operations, Celgene Corporation
Maria Fardis, President and CEO, Iovance Biotherapeutics
Steven Kelly, President and CEO, CARISMA Therapeutics
Christopher Vann, Chief Operating Officer, Autolus Therapeutics

9:05am – 9:50am | The Outlook for Gene Therapy in 2019

Dan Faga, Chief Business Officer, Spark Therapeutics
Matthew Kane,
 Co-Founder and CEO, Precision BioSciences
Matthew Patterson,
 Chairman and CEO, Audentes Therapeutics; Chairman, Alliance for Regenerative Medicine (chair)
Arthur Tzianabos,
President and CEO, Homology Medicines
Jeffrey Walsh, Chief Financial and Strategy Officer, bluebird bio

9:50am | Program Close

 

View the 2018 Webcast

Couldn’t attend last year’s program but want to see what this Briefing is all about? View the full webcast below and download the 2018 Industry Update PPT presentation below.

To see all three of the video options click on the horizontal bars in the upper left corner.

Download Presentation

Date:
January 7, 2019

Location:
Parc 55 San Francisco, A Hilton Hotel

55 Cyril Magnin St.
San Francisco, CA 94102

Who Attends?

Over 500 of the cell and gene therapy field’s top stakeholders including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.

 

Questions?
Please contact Laura Parsons at lparsons@alliancerm.org.